Stacked
OtherResearch profile

Teriparatide

Forteo · rhPTH(1-34) · Recombinant PTH 1-34

Think of it as a bone-building coach for your skeleton.

Teriparatide is like a personal trainer for your bones. It encourages them to bulk up by signaling your body to build more bone than it breaks down. This can be especially helpful if you're dealing with bone thinning issues that make you prone to fractures.

Unlike other treatments that simply slow down bone loss, Teriparatide actively promotes new bone growth. It's a bit like flipping a switch that tells your body to focus on adding strength and density to your skeleton, which can help reduce the risk of fractures in areas like your spine and hips.

Who it's for

  • Postmenopausal women worried about bone strength
  • Active seniors looking to reduce fracture risk
  • People with severe bone thinning issues

Probably not for you if…

  • Anyone looking for a long-term solution beyond two years
  • Those without a prescription from a healthcare provider
  • People uncomfortable with daily injections

Editorial summary for research context · Not medical advice

Mechanism of Action

Teriparatide is a recombinant form of the biologically active N-terminal 34 amino acids of human parathyroid hormone (PTH 1-34). Unlike continuous PTH elevation, intermittent daily subcutaneous dosing preferentially activates osteoblasts over osteoclasts, producing net bone formation. Research has established increases in bone mineral density and reductions in vertebral and non-vertebral fracture risk in postmenopausal osteoporosis. Teriparatide is FDA-approved (Forteo) for severe osteoporosis and glucocorticoid-induced osteoporosis; prescription required. Cumulative lifetime use is capped at 2 years due to osteosarcoma signals in rat carcinogenicity studies.

Researched Benefits

Bone mineral density increase

Pivotal Phase 3 Fracture Prevention Trial demonstrated significant increases in lumbar spine and femoral neck BMD.

  • [Neer et al. 2001]

Vertebral and non-vertebral fracture reduction

Daily SC teriparatide reduced new vertebral fractures by approximately 65% and non-vertebral fragility fractures in postmenopausal women.

  • [Neer et al. 2001]

Anabolic (bone-forming) mechanism

Research distinguishes teriparatide from antiresorptive agents by direct osteoblast stimulation.

  • [Hodsman et al. 2005]

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

FDA-approved dosing (Forteo) — prescription required

Dosage
20 mcg
Frequency
once daily
Timing
any time
Cycle
104 weeks

FDA label: 20 mcg SC once daily; total cumulative lifetime use is capped at 2 years. Prescription and physician supervision required.

Reported Side Effects

  • Orthostatic hypotension and dizziness, particularly after first doses
  • Nausea and headache
  • Leg cramps
  • Transient post-dose hypercalcemia
  • Injection-site reactions
  • Osteosarcoma risk signal from rat carcinogenicity studies (basis for 2-year cumulative use cap)

Contraindications

  • Conditions with increased baseline osteosarcoma risk (Paget's disease, prior skeletal radiation, open epiphyses)
  • Preexisting hypercalcemia or primary hyperparathyroidism
  • Severe renal impairment
  • Pregnancy and lactation
  • History of skeletal malignancy or bone metastases

Stacking Partners

Peptides commonly paired with Teriparatide in published research and protocol write-ups.

Vendor Pricing

No tracked vendors carry this peptide yet. Check back as we add more affiliate partners.

Gear + Companions

Reconstitution supplies and research-backed supplement companions for Teriparatide. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.

Gear you'll need

· Reconstitution + storage essentials
  • Bacteriostatic Water 30mL (0.9% Benzyl Alcohol)

    Empower Pharmacy / generic medical supply

    Reconstitutes every lyophilized peptide. 28-day viability refrigerated.

  • Insulin Syringes 31G × 5/16" × 0.5mL (100 count)

    EasyTouch

    31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.

  • Alcohol Prep Pads (Sterile, 200 count)

    Dynarex

    Sterile 70% IPA prep pads — one per vial stopper + one per injection site.

  • 1-Quart Sharps Disposal Container

    BD / Becton Dickinson

    FDA-cleared sharps container — pharmacies won't accept improvised disposal.

As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines

Top Videos

Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.

Research Papers

  • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

    Neer RM, et al. · New England Journal of Medicine · 2001

    PubMed 11346808
  • Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use

    Hodsman AB, et al. · Endocrine Reviews · 2005

    PubMed 15798098